Clinical Trial Update: Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing FOLFOX4 (oxaliplatin plus 5-FU/leucovorin) versus doxorubicin as palliative chemotherapy in advanced hepatocellular carcinoma; trial com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Doxorubicin (doxorubicin)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sanofi | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: COMPLETED